• Consequences of novel Coronavirus infection on brain health are significant, requiring frequent brain monitoring
• Brain diagnostics in infected patients extremely limited due to their severe physical illnesses; traditional EEG time consuming, exposes frontline workers to virus transmission risk
• BRSF’s sanitary disposable NeuroCap(TM) helps health care workers get quick, reliable insights into patient’s condition while minimizing cross-contamination risk

Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company providing next-gen solutions to the neurology market, is poised to offer a response to brain diagnostic challenges in the hospitals’ red zones amid the pandemic. As the Company describes in one of the recent articles published on the website, the consequences of the COVID-19 pandemic on brain health are significant (https://ibn.fm/fhYxm).

While respiratory damage of novel Coronavirus is well reported, debilitating and even deadly neurological conditions may be affecting far more people infected with the virus. As the pandemic unravels and we learn more about the COVID-19, it is becoming clear that, although COVID-19 does not appear to directly attack nerve tissue, it is neurologically damaging. It is known to cause neurological injury in 1 out of 7 patients hospitalized with the infection (https://ibn.fm/aTUhK). The list of neurological diseases associated with COVID-19 infection is long and includes encephalopathy, Guillain-Barré syndrome, hemorrhagic stroke, ischemic stroke, meningoencephalitis, paralysis, and seizures. A growing body of evidence suggests that COVID-19 can have serious and potentially long-lasting effects on the brain — as many as 1 in 3 COVID-19 survivors experience neurological or a mental health disorder within six months of the infection (https://ibn.fm/Bop48).

COVID-19 appears to cause neurological injury through three mechanisms, including hypoxemia — the state of very low blood oxygen levels causing encephalopathy and neurological damage; immune dysfunction causing “cytokine storm” and blood clots.

Neurological conditions associated with COVID-19 are challenging to diagnose. For example, the diagnosis of encephalopathy, one of the most frequently occurring neurological conditions in COVID-19, is mainly clinical and heavily hindered by the severe physical illnesses of hospitalized infected patients. Investigative procedures such as MRI, lumbar puncture and cerebrospinal fluid analysis are complicated to perform on ICU patients that are on supportive care measures such as mechanical ventilation and supplemental oxygenation.

The quest for a diagnostic procedure that may offer a response in this extremely difficult and limiting setting is still ongoing – but EEG may be able to offer a solution.

EEG could be a potentially helpful study to conduct on patients with suspected COVID-19 encephalopathy. Bedside EEG testing may reveal occult, subclinical seizure activity that would otherwise go unveiled. Still, traditional EEG testing is a time-consuming task that requires placing electrodes and measuring the patient’s head, which all prolongs exposure of frontline health workers to the deadly virus.

When fighting a highly contagious disease, disposable technology is vital. This is where NeuroCap(TM) and NeuroEEG(TM), the Company’s two FDA-cleared devices, can help. They offer cost-efficient, portable neurological monitoring. With sanitary, disposable EEG caps, BRSF’s revolutionary solution helps health care workers get a quick, reliable picture of a patient’s condition while ensuring that the virus is not spread through equipment. BRSF’s EEG caps designed for single use are also easy to place – within minutes – which helps shorten person-to-person exposure, minimizing cross-contamination risk between staff and patients.

For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

• The BevCanna team has decades of combined experience creating, branding and manufacturing iconic brands that resonate with consumers on a global scale
• BevCanna owns and operates world class infrastructure, including a 40,000-square-foot, HACCP certified manufacturing facility with a current bottling capacity of up to 210 million bottles per year for both traditional and cannabis-infused beverages, and an alkaline spring water aquifer located onsite
• The company delivers a diverse portfolio of beverages and nutraceuticals for both in-house brands and white labeled products
• BevCanna leverages a proven direct-to-consumer e-commerce strategy to sell a range of natural health products throughout North America and Western Europe
• The company has provided strong revenue guidance through multiple streams, including white labeling, joint-ventures, licensing, brand building and e-commerce direct to consumer

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a diversified health & wellness beverage and natural products company focused on developing and manufacturing a range of plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. The BevCanna team boasts decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale. BevCanna’s distribution network features more than 3,000 points of retail distribution through the company’s market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network and its partnership with #1 U.S. cannabis beverage company Keef Brands. Based in British Columbia, Canada, BevCanna was founded in 2017. End-to-End Turnkey Beverage Manufacturing Solutions BevCanna is a manufacturer of traditional and cannabis-infused beverage brands serving a growing roster of white-label clients, in addition to operating a portfolio of in-house and partner brands. The company offers a full-service white label beverage manufacturing solution.

• Processing – At its state-of-the-art beverage manufacturing facility, BevCanna partners with industry leaders specializing in crude extraction, refinement, purification and solubility conversion to provide high-quality water-immiscible emulsions that maximize bioavailability, clarity and taste.
• Spring Water – BevCanna directly owns a pristine naturally alkaline spring water aquifer in British Columbia.
• Product Development – BevCanna leverages its expertise to develop captivating flavors based on category and consumer insights in order to enhance product positioning.
• Packaging – A variety of packaging options are offered by BevCanna, including beverage and nutraceutical formats such as PET, aluminum and glass, available in a variety of standard and custom sizes and shapes.
• Beverage Manufacturing: Traditional & Cannabis Facilities – The company’s 40,000-square-foot beverage manufacturing facility is HACCP (Hazard Analysis Critical Control Point) Certified. The facility’s capabilities include blow molding, dosing, carbonation options, filling and capping, pressure sensitive and shrink-sleeve label applications, flash pasteurization, QA testing and packing/palletizing for shipment.

Pure Therapy, TRACE and Partner Brands BevCanna’s in-house brands include Pure Therapy and TRACE. Pure Therapy is a direct-to-consumer e-commerce brand that markets a range of natural health products, including nutraceuticals and hemp-based cannabidiol (“CBD”) products, throughout North America and Western Europe. Pure Therapy has secured orders from over 23,000 customers since its inception in 2017. BevCanna expects strong growth through Pure Therapy over the next 12 months driven by new product integration, accelerated growth of existing products and its marketing team’s e-commerce expertise. TRACE products feature the Naturo Group’s proprietary plant-based fulvic and humic mineral formula, sourced from deep within the Rocky Mountains of interior British Columbia. These unique and ancient minerals provide wellness properties that include iron, magnesium, calcium, potassium and many other minerals no longer found in our food chain at adequate levels. Research suggests that the proprietary fulvic and humic organic compounds found in TRACE products could offer a number of key benefits, including promoting gut health, immune function, cognitive performance and whole-body wellness. TRACE products include Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water, Natural Flavor Sparkling Spring Water, Plant-Based Mineral Concentrate with Vitamin D and Plant-Based Mineralized Immune Support Shots. In addition to its in-house brands, BevCanna provides white-label services to a number of partners in its space. BevCanna’s current portfolio of brand partnerships includes #1 U.S. cannabis beverage brand Keef (cannabis-infused classic soda) and BLOOM (live resin & high-end extracts). BevCanna also has multiple white label agreements to co-manufacture branded beverages. Market Outlook for Cannabis-Infused Beverages In 2018, the cannabis-infused beverage market was valued at $901.8 million. The market is expected to grow during the forecast period of 2019 to 2025 at a CAGR of 17.8%, resulting in a market value in excess of $2.84 billion by 2025, according to Grand View Research (https://ibn.fm/VkJfH). The projected growth is largely attributed to the legalization of recreational and medical marijuana in multiple jurisdictions. Cannabis-infused beverages are uniquely positioned to provide an alternative to a large portion of the edibles market, including items such as chocolates, cookies, gummies and other types of confectionery pieces. Management Team Marcello Leone is the CEO and Founder of BevCanna. He is also the founder of Naturo Group and the TRACE brand. John Campbell is the CFO and CSO of BevCanna. He has over 30 years of experience in the investment industry, including time with TriView Capital Ltd. Keith Dolo is the company’s Executive Management Advisor, having previously served as CEO and Executive Chairman of Sproutly Inc. Previously, he served for over 13 years with Robert Half (NYSE: RHI), an S&P 500 company, specifically in the role of Vice President for the last eight years. Melise Panetta is the company’s President. She is an accomplished senior marketing and sales executive with extensive experience leading organizations such as SC Johnson, General Mills (NYSE: GIS) and PepsiCo (NASDAQ: PEP). Ms. Panetta has nearly 15 years of deep marketing and sales expertise. Raffael Kapusty is the company’s Vice President of Sales & Insights. She is an accomplished CPG industry leader with more than 25 years of experience in both the Canadian and U.S. retail spaces. With a solid foundation at ACNielsen Canada (NYSE: NLSN), Ms. Kapusty has developed a deep understanding of the CPG space, working with over 100 leading Canadian & global CPG manufacturers. She has also held senior category and key account management roles at Kroger (NYSE: KR), SC Johnson and Unilever Canada (NYSE: UL). Bill Niarchos is the company’s Vice President of Sales & Sales Operations. He has over 20 years of experience in the CPG goods industry/retail environment. In his most recent role as Director of Sales with Bayer Consumer Health, Mr. Niarchos managed the strategic direction and growth of Loblaw & SDM. Prior to his position with Bayer (ETR: BAYN), Mr. Niarchos held a number of progressive roles at Colgate Palmolive (NYSE: CL) for more than 14 years. Japheth Noah is the company’s Head of Quality Assurance. He is an Oxford and MIT educated quality and regulatory manager with over 15 years of experience in the beverage, pharmaceutical, natural health and medical industries. Keith Stride is the company’s Creative Director. He has 25 years of experience in marketing and advertising, including time in a CMO role with Hemptown USA. Mr. Stride is internationally recognized for building high-profile brands, including Rogers (NYSE: RCI), TD Bank (NYSE: TD), Best Buy (NYSE: BBY), Whistler-Blackcomb and RBC (NYSE: RY). For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

• Nextech recently signed a letter of intent to acquire all outstanding shares of Threedy.ai Inc. Threedy’s AI-enabled technologies create 3D models from 2D images through a six-stage assembly line, integrated into a single platform. Nextech intends to assimilate Threedy’s platform into its AR ecosystem
• The company also announced it has been designated as the preferred vendor by Visit Tampa Bay, a not-for-profit organization
• NTAR recently launched “LiveX,” its Digital Experience Platform, and plans to showcase it in a June 29 signature event featuring Gary Vee as the keynote speaker

Toronto-based Nextech AR Solutions (CSE: NTAR) (OTCQB: NEXCF) recently announced it has signed a binding LOI to acquire all outstanding shares of California-based Threedy.ai Inc (“Threedy”). The acquisition, expected to be completed mid-June, will be based on an all-stock offer in which US$9.5 million worth of Nextech’s common shares will be issued to Threedy’s shareholders (https://ibn.fm/bg5PZ). Founded in 2018, Threedy envisions a commerce world wherein every physical product has an exact 3D digital replica. To achieve this vision, the startup builds proprietary artificial intelligence (“AI”) technologies and computer vision innovations that create 3D models of physical products from 2D photos at scale through a six-stage assembly line. The 3D model creation process, carried out within a single integrated platform, starts with the automatic onboarding of product photos using a simple JavaScript tag. The AI then creates 3D models of each item, which are hosted on Threedy’s cloud. The platform subsequently serves 3D visualizations using web-based augmented reality (“AR”) or 3D viewing applications. These steps can be summarized as ingest, segment, create, paint, assemble, and package. This AI-enabled product, coupled with the guidance of the leadership team comprising seasoned entrepreneurs and scientists, has enabled Thready to forge relationships with many clients in the commerce industry, including Wayfair, Walmart, Lighting Plus New Zealand, K-mart Australia, Kohl’s Pier 1 Imports, and more. With the buyout, which is part of Nextech’s acquisition strategy to create new revenue opportunities and grow, Nextech intends to assimilate Threedy’s AI-powered integrated platform into its AR ecosystem. It envisions that this product will become the self-service AR platform for all its AR solutions, which include holograms, AR portals, e-commerce, AR advertising, and more. Further, the acquisition will enable both Nextech and Threedy to bridge the content creation gap between 2D and 3D and center AI technology within the digital transformation economy. “With Threedy’s technology and Nextech’s global sales and marketing machine, our combined AI teams, and our existing AR tech and resources as a public company, I’m convinced that we will quickly take a leadership position in the AR industry,” stated Nextech CEO Evan Gappelberg. As a developer of a better industry solution for creating 3D models and content, Threedy is well placed to scale with the rapid adoption of AR around the world. In fact, the startup’s game-changing product is the first ever to create digital replicas easily, fast, and cost-effectively manner. It, therefore, significantly benefits major retailers and manufacturers, which, for a long time, could not expand their 3D digital inventories fast enough and cost-effectively. At the time, the biggest bottleneck used to be the inability to create 3D models at a scale. But not any longer. Elsewhere, Nextech also made two notable announcements recently, the first being that it has been chosen as the preferred vendor by Visit Tampa Bay, a not-for-profit organization that encourages visitors to unlock the sun, fun, and culture in Florida’s most diverse travel destination (https://ibn.fm/mWniD). While the partnership mainly concerns Nextech’s e-commerce segment, it is strategic because it extends the company’s reach by providing an opportunity to connect with confirmed conferences to host virtual and hybrid events on its virtual experience platform (“VXP”). Additionally, on May 12, NTAR released its Digital Experience Platform, “LiveX”, the AR industry’s first-ever all-in-one platform that supports AR advertising, AR e-commerce, AR products, and augmented digital experiences. The company plans to showcase LiveX in a signature event, dubbed “LiveNow,” to be held Tuesday, June 29, 2021, at 10 am Eastern Time (https://ibn.fm/foRW2). LiveNow will feature entrepreneur and internet personality Gary Vaynerchuk (better known as Gary Vee) as the keynote speaker. For more information, visit the company’s website at www.NextechAR.com. NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

• Sequire Investor Community designed to act as community hub for millions of retail and institutional investors currently engaging with the Sequire platform
• Sequire recently released details of its extensive conference schedule, which will cover themes including cannabis, blockchain, clean tech, fintech, and micro-cap equities
• SRAX also introduced addition of Morgan-Lea Fogg, who will be joining SRAX team as community development manager charged with Sequire Investment Community creation

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced the launch of the Sequire Investor Community, an information hub and interactive environment designed to cater to the platform’s growing network of investors (https://ibn.fm/3aDBb). The Sequire Investor Community will seek to function as a bustling, synergetic community hub for the millions of retail and institutional investors currently engaging within the Sequire platform. To support the rising number of investors on its platform, Sequire will seek to create a live and on-demand virtual space, enabling investors to congregate to learn, share and network on a wide range of industry related topics. The launch of the Sequire Investor Community comes shortly after the Company’s release of its extensive upcoming conference schedule for the year (https://ibn.fm/UONdG). Devised to add further value to the millions of investors and shareholders currently using its platform, Sequire’s slate of upcoming conferences will include events such as the LD Micro Invitation XI (June 8-10), the Sequire Blockchain Conference (July 15), the Sequire Edtech Conference (September 13), and the Sequire Clean Tech / EV Conference (October 14), among various others. “We are excited to kick off our conference series and to provide our Sequire clients a platform to reach a large audience of both retail and institutional investors,” stated SRAX CEO and Founder Christopher Miglino. In addition to hosting industry specific conferences within the platform’s Virtual Event space, Sequire also plans to host a variety of educational masterclasses while simultaneously publishing a series of value-added newsletters on topics such as technical and fundamental investing with the help of LD Micro, SRAX’s micro-cap focused subsidiary. “We are leveraging the investors and experts from the LD Micro community to enhance relationships and communications with investors,” continued Miglino. “In addition to the LD Micro investor events, we’re hosting industry specific conferences, and planning a variety of resources and experiences to benefit this growing community.” SRAX also announced that Morgan-Lea Fogg had joined the SRAX team as Community Development Manager, charged with the creation of the Sequire Investor Community. Fogg, who was previously at Summit Series, an organization designed to foster global communities through invitation-only events, brings over seven years of experience within the event planning and community creation space to her new role. Morgan-Lea Fogg said in relation to the Sequire Investor Community, “Our goal is that the Sequire Investor Community will become a well-known hub, providing exceptional tools and experiences that will allow people to learn and participate in the everyday activity happening within the stock market.” For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Florida is the third-largest market by revenue in the US, bringing in over $1.2 billion in 2020 for medical cannabis
• Once the acquisition of Acreage Holdings is finalized, RWB will mobilize 30 turn-key grow pods for cultivation
• RWB acquired licenses to open 35 dispensaries in Florida, a limited license state, more than doubling the current number there

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a super state operator of American Cannabis, targets individual states in the United States, dominating one state before expanding into another. The company’s commitment exceeds the requirements of each state in which it operates. Beginning in Michigan, RWB currently has its eyes on the third largest market by revenue in the United States, Florida. “Our core strategy has always been to focus on a limited number of markets within which to operate at scale, and Florida has always been one of those targeted markets,” stated Brad Rogers, Chief Executive Officer of RWB. In February, RWB announced the acquisition of Florida operations from Acreage Holdings that included eight leased locations and the ownership of a 113,000 square feet cultivation and processing facility on 15 acres of land (https://ibn.fm/Fl7jD). Once the acquisition is completed, RWB plans to increase cultivation capacity. The majority of Florida’s medical cannabis market is mass produced flower of common strains. And still, the state has one of the strongest markets in the US, with revenue reaching over $1.2 billion in 2020.  RWB is looking to meet Florida’s demand for a more premium product and has acquired 30 double wide fully enclosed cultivation pods to help expedite production to support store openings. The company has already obtained licenses to open 35 dispensaries in the state (https://ibn.fm/yA8xZ), an accomplishment in a limited license state with only 22 licensed operators (https://ibn.fm/6S3En). Once online, these pods will provide around 19,000 square feet of operating space with a 14,400 square feet canopy. Combined, they can produce over 7000lbs of flower and thousands of pounds of trim yearly. The estimated annual value that these units will produce is $40 million (https://ibn.fm/PqfVS). From the beginning, RWB has followed a top-down approach to cultivation developed under the guidance of scientific experts in growing principles. By using science-driven production methods and automated, sustainable manufacturing practices, they can operate at an industrial scale. Red White & Bloom adheres to the highest ethical, manufacturing, education, branding, and employment standards available in the industry. Through strategic acquisitions, a super state operator model, and a commitment to top-quality on every level, RWB is positioned to become one of the top three multi-state cannabis operators in the US legal cannabis and hemp markets. For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

• Asia Broadband is increasing its physical gold holdings, to financially leverage and back the company’s AABBG cryptocurrency token, through acquisitions of historic gold mine site properties
• The company is currently at an advanced stage of negotiations and due diligence process for the purchase of the 200-hectare Los Reyes property in western Mexico, whose assay results show significant promise
• AABB also announced that it has entered into an LOI to acquire a high-yield asset in the prolific mining region of Acaponeta in Nayarit, also in western Mexico

Asia Broadband (OTC: AABB), a resource company operating using a vertically integrated model that sees it produce, supply and sell precious and base metals, primarily to Asian markets, is committed to strategically increase its physical gold holdings, to financially leverage and back the company’s AABBG cryptocurrency token, by acquiring gold production and high potential gold properties. Driven by this goal, AABB recently made notable strides that are expected to culminate in the acquisition of properties located in two prolific mining regions of Mexico.

The first property – the Los Reyes property – located in the region of Mascota in Jalisco, Mexico, and covering an expansive area of 200 hectares, has two mine sites and houses on-site processing facilities, including one capable of processing 50 tons of gold per day (https://ibn.fm/e78Wq). Asia Broadband recently received the mapping and rock sample assay results for this property as part of a due diligence process that entails performing an expert review of the technical parameters of an asset.

The results from non-targeted rock samples showed great promise for AABB and strongly demonstrated that targeted drilling samples, directed by geophysics data, could have higher gold concentrations and values. Asia Broadband intends to continue conducting more due diligence procedures, as well as furthering negotiations to acquire the property as a fulfillment of the letter of intent (“LOI”) it had signed in early March (https://ibn.fm/gTnjQ). The property has an estimated asset value of $30 million.

AABB’s sights are also set on a second property located in the region of Acaponeta in Nayarit, Mexico, as indicated by a recent announcement in which the company reported it had signed an LOI to acquire the asset (https://ibn.fm/pjCBG). The property has two mine sites, existing infrastructure and a processing facility capable of processing 200 tons of gold per day. Considered a high-grade acquisition target, the asset is located about 48 kilometers southeast of Acaponeta city and 3 kilometers from El Carrizo town.

Asia Broadband anticipates that the Acaponeta project, which has the potential for rapid development, will offer high gold production at low operating costs. In the next few weeks, the company will carry out additional due diligence procedures, including mapping and rock sampling programs, and continue its negotiations to purchase the $11 million property. As part of the initial due diligence, AABB conducted some rock sample tests whose assay results are expected in the coming weeks.

The company noted that efforts were underway to accelerate the Acaponeta project’s acquisition and expeditiously commence production. AABB also stated that once it reaches a definitive agreement, it would avail additional information, such as location details, photos and mineralization data. A look at the company’s new YouTube channel shows that AABB may have reached this point. The channel features short videos showcasing the Los Reyes and Acaponeta properties. You can watch the videos here (https://ibn.fm/izcDY).

For more information, visit the company’s website at www.AsiaBroadbandInc.com.

NOTE TO INVESTORS: The latest news and updates relating to AABB are available in the company’s newsroom at https://ibn.fm/AABB

• Company pleased that independent review has confirmed fair value of Veteran Hemp Co. asset acquisition
• HENC entered into purchase agreement to acquire all assets of Veteran Hemp Co. in November 2020
• Hero Technologies CEO noted that “acquisition is in line with our company’s growth strategy of adding accretive assets to our portfolio”

Hero Technologies (OTC: HENC), a cannabis company focused on a vertically integrated strategy, has received an independent third-party valuation and purchase price allocation for its acquisition of the assets of V Broker LLC., or Veteran Hemp Co. (https://ibn.fm/sPttR). “We are pleased that an independent review has confirmed the fair value of our Veteran Hemp Co. asset acquisition,” said Hero Technologies CEO Gina Serkasevich. “As we continue to develop and execute our integrated ‘seed to sale’ market strategy for cannabis products, we strive to make wise investment decisions. Our carefully considered purchase of Veteran Hemp Co. benefits our balance sheet, our market reach—both retail and wholesale—and our shareholders.” In November 2020, Hero Technologies entered into a purchase agreement to acquire all the assets of Veteran Hemp Co. from Patriot Shield National LLC (https://ibn.fm/uttjm). At the time, Serkasevich noted that “this acquisition is in line with our company’s growth strategy of adding accretive assets to our portfolio. Not only does this business fit into our goals, but we also anticipate great synergies through Ross’s deep connections and relationships in the cannabis industry.” Andrew Ross was CEO of Patriot Shield at the time of the acquisition, and Hero Technologies engaged him to continue running Veteran Hemp Co. and to serve as the company’s security advisor. Veteran Hemp Co. prides itself on offering hemp that is tested, tasted, and veteran approved. The company is committed to providing a quality, consistent, delicious product, and it accomplishes that objective by only working with the best farmers in the country, delivering them the best genetics, helping at every point along the way, and then packaging only the best product. The news of the third-party valuation and purchase price allocation validates HENC’s acquisition of the veteran-founded, Colorado-based online retailer and wholesaler of hemp and cannabinoid products. According to the valuation, which was calculated by Doty Scott Entreprises, the acquired assets from Veteran Hemp are valued at $169,711. The report noted that the acquisition improved Hero Technologies’ balance sheet with $140,805 in total tangible assets, $71,526 in net tangible assets, and $98,195 in intangible assets, including trade names, customer base, and goodwill. Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. The company’s strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multi-state operator (“MSO”). For more information, visit the company’s website at www.HeroTechnologiesInc.com. NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://ibn.fm/HENC

• Affiliate program designed to authorize third-party resellers that meet certain guidelines to market, sell exclusive Grapefruit products
• Program will maximize, facilitate distribution of GPFT’s THC-free, hemp-derived CBD Hourglass-powered products
• Grapefruit’s program also provides invaluable product training and information

On the heels of unveiling its new e-commerce store, Grapefruit USA (OTCQB: GPFT) added to the excitement by announcing a new affiliate program. The program is designed to authorize third-party resellers that meet certain guidelines to market and sell the company’s proprietary THC-free, hemp-derived CBD Hourglass(TM)-powered products (https://ibn.fm/rKKv7). “[Recently] Grapefruit launched a new Affiliate Program to maximize and facilitate distribution of our THC-free, hemp-derived CBD Hourglass-powered products,” said Graperfruit CEO Bradley Yourist. “We feel the new affiliate program will allow Grapefruit to rapidly increase public availability of our [. . .] product lines and enhance Hourglass brand awareness across the U.S. and internationally. The public will only be able to buy the vastly superior patented Hourglass time-release, hemp-based CBD topical cream-based products from Grapefruit and/or its authorized agents and affiliate resellers.” In addition to authorizing affiliates to carry the exclusive products, Grapefruit’s program provides training and information so that affiliates can become knowledgeable about Grapefruit’s cannabis plant-based products as well as the company’s culture and brand. This aspect of the program assists affiliates in becoming prepared to market and sell Grapefruit’s extraordinary products as soon as they become legally available in an affiliate’s jurisdiction. The potential benefit for both affiliates and Grapefruit is impressive. A recent Statista report noted that the U.S. affiliate-marketing spend is projected to reach $8.2 billion next year, almost $3 billion more than the $5.4 billion reported in 2017. The affiliate program creates a can’t-miss opportunity to market and sell Grapefruit products. Grapefruit has built a reputation for offering only the highest-quality products, with each product undergoing rigorous independent testing. The company has committed to making no product claims without clinical validation, so consumers can be confident when they choose Grapefruit. All of Grapefruit’s THC-free, hemp-derived, CBD-based products marketed and sold on the new e-commerce website and through the affiliate program are thoroughly tested and include a QR-coded certificate of analysis, which provides a complete list of third-party-verified ingredients certifying each product’s cannabinoid content, purity and safety. Currently, Grapefruit’s flagship product — Hourglass time-release delivery cream — is the main focus on the e-commerce site and in the affiliate program. The topical cream features cutting-edge science and technology that solves the age-old problem of THC and other cannabinoids not being easily absorbed through the skin. The company’s Hourglass topical cream uses patented microsized particles to slowly deliver THC and a wide range of cannabinoids through skin topical administration. No other topical cream product on the market provides users with the holistic benefits of the range of cannabinoids found in Hourglass. To find out more about the company and its game-changing Hourglass time-release cannabinoid delivery cream, please visit www.GrapefruitBlvd.com. NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at https://ibn.fm/GPFT

• AmpliTech Group Inc. announced it had been selected to provide its ultra-low noise amplifiers
• The trial order, issued by a major Fortune 200 defense contractor, is valued at approximately $120,000
• The order for a space program offers AmpliTech the opportunity to demonstrate its capabilities
• It is among other positives that, combined, could drive an important financial turnaround

AmpliTech Group (NASDAQ: AMPG, AMPGW) recently reached a milestone deemed an opportunity for the company to demonstrate its capabilities. The company, which designs, develops and manufactures custom radio frequency (“RF”) components for satellite communications (“SATCOM”), commercial, space, defense and military markets, as well as products for the 5G/6G wireless ecosystem, announced it had been selected by a major Fortune 200 defense contractor to provide its ultra-low noise amplifiers in a trial order valued at about $120,000 (https://ibn.fm/c9uCA). AmpliTech, which prides itself on being a company built on experience, proven technical expertise, superior design heritage and complete customer satisfaction, has developed high-quality amplifiers for use in space-borne satellites and probes that orbit around the earth. Given the rigors of launching and the requirement to maintain the highest performance in a space orbit for many years, AmpliTech builds these parts using specially developed techniques and procedures that it has continually perfected. The company focuses on being a reliable supplier of high-quality amplifiers for use in situations where the best performance is needed. It is this quality that Fawad Maqbool, AmpliTech’s Founder and CEO, alluded to in his statement following the announcement. “Once again, the importance of having the leading-edge performance in the amplifiers is a major factor for the selection, along with our capability to deliver the highest quality as well,” he said. This trial order for a space program buttresses Fawad’s outlook for the remainder of the fiscal year 2021. It follows a similarly positive announcement in which AmpliTech reported that its order backlog had reached $2.2 million at the end of the first quarter of 2021. At the time, Fawad noted that the increased backlog was indicative of growing demand and revenues in the upcoming quarters (https://ibn.fm/gN6Fy). Combined, these positives will be instrumental in helping AMPG bounce back from a financially disappointing year that saw it report a net loss of $1.03 million for the period ended December 31, 2020, down from a net income of $5,945 in 2019. This sharp drop occurred despite an increase in revenue year over year of 11%. According to its Form 10-K filing (https://ibn.fm/SJEYN), AmpliTech’s slip into the red was attributable to the Covid-19 pandemic, as well as an increase in costs related to selling and general and administrative expenses of approximately 46.24% from $1.48 million in 2019 to $2.17 million in 2020. Nonetheless, the company clarified that it expects to continue its business efforts and not shut down – due to pandemic-induced causes – unless otherwise mandated, but also painted a grim picture of 2021 in its outlook for the same reason. “Difficulties in communicating with our customers’ employees and delivery delays due to COVID-19 may impact our ability to meet customer demand, and thus decrease revenue into 2021 and negatively impact our financial condition and results of operation,” reads an excerpt from the 10-K filing. Thus, the trial order is seen as an opportunity for AmpliTech to demonstrate its capabilities on multiple fronts, including proving the forecasted inability to meet customer demand wrong and may well provide the impetus for a financial turnaround by opening AMPG up to an even larger order. For more information, visit the company’s website at www.AmpliTechInc.com. NOTE TO INVESTORS: The latest news and updates relating to AMPG are available in the company’s newsroom at https://ibn.fm/AMPG

• Seizures have been common in hospitalized COVID-19 patients, and the death rate higher in those who experienced the seizures
• Due to a shortage of PPE and limited contact, EEG accessibility was limited during the pandemic
• The  NeuroCap can fill the gap in EEG accessibility during the pandemic and into the future, as more long-term studies are created

Brain Scientific (OTCQB: BRSF) is developing innovative and proprietary medical devices and software to bridge the widening gap in access to quality care. The Company’s first commercialized devices, the NeuroCap(TM) and NeuroEEG(TM), offer cost-effective and disposable substitutes to their traditional counterparts. The NeuroCap is FDA-cleared, minimizes cross-contamination, and can be administered by clinical staff of any level. With over one-third of coronavirus patients reporting neurological symptoms, more patients must receive EEGs that allow for limited contact and ease of use. The NeuroCap takes less than five minutes to set up, can remain on the patient’s head for up to four hours, and is disposable, making it more sanitary than the bulky wires of traditional EEGs that require constant cleaning. Throughout the pandemic, seizures have been common in hospitalized COVID-19 patients, and the death rate higher in those who experienced the seizures (https://ibn.fm/rMqOU). “Patients as a whole are at significantly high risk of seizures when they’re critically ill in the ICU,” stated Richard Temes, a neurologist at Northwell Health in New York in an article published by The Scientist. “The only way that you detect these seizures oftentimes is by capturing the seizure activity on the EEG.” Monitoring a patient’s brain waves lets the physician know how best to treat the patient. However, due to a shortage of personal protective equipment (“PPE”) and the need to limit interaction with patients, only the sickest patients were receiving EEGs during the beginning of the pandemic. With time it was discovered that what was thought to be only a respiratory syndrome had a significant effect throughout the body and the brain, resulting in a wide range of cognitive effects from brain fog to strokes. According to The Scientist, the number of seizures was similar to the number reported for patients hospitalized with other illnesses. The seizures might not be COVID attacking the brain or causing brain damage, but rather the severity of the disease. Right now, it is unknown how COVID-19 affects the brain. More studies are needed. The NeuroCap is ideal for this type of study for several reasons:

• Pre-gelled fixed electrode placement makes it easy to apply by frontline healthcare workers, no specialized EEG technicians needed (https://ibn.fm/Pietm)
• Application takes less than five minutes, limiting the time of contact with the patient
• Disposable and sanitary
• Available in multiple sizes, including pediatrics
• Cost-effective

Brain Scientific is working toward improving patients’ access to neurological care. The NeuroCap can fill the gap in EEG testing availabilities during the COVID pandemic and beyond as more long-term studies are created. For more information, visit the company’s website at www.BrainScientific.com/Invest-Now. NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF